Anti-Dopamine Transporter, C-Terminus Antibody

Our Anti-Dopamine Transporter, C-Terminus rabbit polyclonal primary antibody from PhosphoSolutions is produced in-house. It detects human, mouse, non-human primate, and rat Dopamine Transporter, C-Terminus and is antigen affinity purified from pooled serum. It is great for use in WB, IHC.

Primary Antibody
Human, Mouse, Non-Human Primate, Rat
Antigen Affinity Purified from Pooled Serum
80 kDa

Go to Full Product Details

Anti-Dopamine Transporter, C-Terminus Antibody

Volume: 100 µL
Sale price$399

Bulk Order Anti-Dopamine Transporter, C-Terminus Antibody

Product Specific References for Applications and Species

Immunohistochemistry: Mouse
PMID Dilution Publication
33345721 1:500 Cuevas, E., et al. 2020. Tauroursodeoxycholic acid (TUDCA) is neuroprotective in a chronic mouse model of Parkinson’s disease. Nutritional Neuroscience, Dec. 21, pp.1-18.
Immunohistochemistry: Rat
PMID Dilution Publication
26321151 1:500 Sarkar, S., et al. 2015. Histopathological and electrophysiological indices of rotenone-evoked dopaminergic toxicity: Neuroprotective effects of acetyl-l-carnitine. Neuroscience Letters, 606, pp.53-59.
Western Blot: Human
PMID Dilution Publication
31529335 not listed Rosas-Hernandez, H., et al. 2019. Stretch-Induced Deformation as a Model to Study Dopaminergic Dysfunction in Traumatic Brain Injury. Neurochemical Research, 44(11), pp.2546-2555.
14535941 1.4ug/ml Haycock, J.W., et al. 2003. Marked disparity between age‐related changes in dopamine and other presynaptic dopaminergic markers in human striatum. Journal of Neurochemistry, 87(3), pp.574-585.
11282256 not listed Kish, S.J., et al. 2001. Striatal dopaminergic and serotonergic markers in human heroin users. Neuropsychopharmacology, 24(5), p.561.

Related Products

Recently Viewed